ArticleFood chemistry: X2025
Role of ellagitannins and OTR of the
Article in Food chemistry: X, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
American and French oak are woods commonly used in cooperage to make barrels. This study analyzed 250 French oak staves to determine the relationship between ellagitannin content and oxygen consumption capacity, as well as the importance of wood grain and its oxygen transfer rate. The study found that castalagin is the most abundant ellagitannin, followed by vescalagin in 37 % of the staves and roburin E in 46 % of them. This allows for the creation of ellagitannin content profiles. It was observed that vescalagin and castalagin occupied the top positions in 7 % of the samples. Additionally, the woods with the highest oxygen consumption capacity were found to have castalagin or vescalagin as the main ellagitannins. Samples with castalagin and roburin E as the main ellagitannins had the lowest consumption capacity. Seven percent of the samples had a castalagin and roburin D profile, which was found to be intermediate.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.